DRIVING BETTER OUTCOMES
Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications
Who we are
Noema Pharma is a clinical-stage biotech developing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms and unique features aimed at delivering meaningful benefits in neurological and related disorders.
OUR PIPELINE
We are advancing three clinical-stage programs in parallel, focused on improving the lives of patients with trigeminal neuralgia, Tourette syndrome and VMS (hot flashes & night sweats) and other menopause-related symptoms.
EDUCATIONAL RESOURCES
We’re committed to sharing important disease-state information that informs patients and helps them foster connections with others living with similar conditions.
Partnerships and Investors
Strategic collaborations and investments enable us to develop world-class treatments for people with rare and often-overlooked conditions of the nervous system.